Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.

International journal of cardiology - 15 Jul 2015

Gallego-Delgado Maria, Gonzalez-Lopez Esther, Garcia-Guereta Luis, Ortega-Molina Marta, Gonzalez-Vioque Emiliano, Cobo-Marcos Marta, Alonso-Pulpon Luis, Garcia-Pavia Pablo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cardiomyopathy, Hypertrophic
Share to Intracellular Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to LIM Domain Proteins

Share to Muscle Proteins

Share to Pedigree

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 25965631
DOI: 10.1016/j.ijcard.2015.04.260

Genes

FHL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.PMID 25965631Read ↗

Clinical spectrum, cardiac phenotypes, and outcomes of FHL1-related cardiomyopathies: a systematic review.Semantic proximity Read ↗

Unraveling the role of the FHL family in cardiac diseases: Mechanisms, implications, and future directions.Semantic proximity Read ↗

Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World.Semantic proximity Read ↗

The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.Semantic proximity Read ↗

Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.Semantic proximity Read ↗

From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathySemantic proximity Read ↗

Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatmentSemantic proximity Read ↗

LZTR1-Related Hypertrophic Cardiomyopathy Without Typical Noonan Syndrome Features.Semantic proximity Read ↗

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.Semantic proximity Read ↗

Clinical Challenges of Genotype Positive (+)–Phenotype Negative (−) Family Members in Hypertrophic CardiomyopathySemantic proximity Read ↗

Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessmentSemantic proximity Read ↗

A lethal pedigree of hypertrophic cardiomyopathy associated with mild left ventricular hypertrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.